ASHLEY KO: Open Payments
NPI 1821462045 · HAVERHILL, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,802 in 46 payments from 22 companies in 2025. Trend: 2023 $23 · 2024 $1,345 · 2025 $2,802
Food & beverage: $2,744Education: $58
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 3 | $289 |
| Amgen Inc. | 3 | $285 |
| Corcept Therapeutics | 6 | $196 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $193 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $190 |
| CeQur Corporation | 1 | $178 |
| Alnylam Pharmaceuticals Inc. | 2 | $168 |
| Viatris Specialty LLC | 3 | $160 |
| Phathom Pharmaceuticals, Inc. | 2 | $153 |
| Janssen Pharmaceuticals, Inc | 1 | $140 |
Products named: REXULTI, REZDIFFRA, Korlym, CAPLYTA, CeQur Simplicity, AMVUTTRA, YUPELRI, VOQUEZNA.
Industry payments across MA — which companies pay providers there.
